Explore Investment Strategies with Exponent is an investment firm that designs comprehensive, tailored portfolios to help achieve your goals. Their approach is based on deep understanding of your needs and uses rigorous research to identify opportunities in the market.

The London office of Debevoise & Plimpton has advised Exponent Private Equity Partners on the closing of its latest fund, raising PS1 billion of commitments. The new Fund IV is expected to target middle-market investments with enterprise values between PS75 million and PS350 million in the UK. The Fund will continue Exponent’s strategy of investing in founder-owned, market-leading businesses to unlock their potential.

The Role of Diversification in Exponent Investment Management’s Strategy

One of the Fund’s early platform investments is Kingsbridge Healthcare Group, which provides healthcare services in Northern Ireland and the Republic of Ireland. The firm is supporting the business to expand its operations, including through an add-on acquisition of Xeinadin Group in Belfast.

Cleary Gottlieb represented the founders of KHG, surgeons Suresh Sharma and Ashok Songra, in a carve-out from US private equity firm 57 Stars. Kingsbridge already operates four hospitals, including the former St Joseph’s Hospital in Sligo, and 11 clinics. It has a growing reputation for cutting NHS waiting lists.

The stock of Exponent, Inc. is currently graded as a Hold with an average rating of 1.57, which is based on our proprietary system that combines quantitative analysis with a wide range of qualitative indicators. This gives investors a more complete picture of the company to assist in making a more informed buy, sell, or hold decision. The proprietary ratings are based on our extensive research across the professional services sector and include grades for Value, Momentum, EPS Revisions, and Quality.